Showing results (1481-1490 of 1,599) with videos related to
Sort By:
Pageof 160
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 13, 1998
Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host diseaseE P Smith, I Sniecinski, A C Dagis, et al.Journal of Cellular Physiology|January 15, 2019
The cancer-related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasisFrancisco Villanueva, Hector Araya, Pedro Briceño, et al.Pharmaceutical Biology|February 15, 2017
Nanoparticle formulation increases Syzygium cumini antioxidant activity in Candida albicans-infected diabetic ratsPaula E R Bitencourt, Lariane O Cargnelutti, Carolina S Stein, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 11, 2016
MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cellsGillian Browne, Julie A Dragon, Deli Hong, et al.Journal of Virology|August 21, 2002
In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteinsYubin Kang, Colleen S Stein, Jason A Heth, et al.Oncogene|January 11, 2012
Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancerE J H Wee, K Peters, S S Nair, et al.Cancer Research|September 10, 2025
Parkin Induces Ubiquitination and Large Extracellular Vesicle Release of HMGB1 to Activate Antitumor ImmunityMinjeong Yeon, Michela Perego, Khaled M Elokely, et al.Oncogene|November 17, 2009
Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesionsJ Akech, J J Wixted, K Bedard, et al.Blood Advances|October 25, 2019
Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemiaNicola Gökbuget, Hagop M Kantarjian, Monika Brüggemann, et al.Journal of Substance Use and Addiction Treatment|March 7, 2023
The experience of re-infection among people who inject drugs successfully treated for hepatitis CAlison Karasz, Krupa Merchant, Reena Singh, et al.Pageof 160